Atricure Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,350

Employees

  • Stock Symbol
  • ATRC

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $54.03
  • (As of Thursday Closing)

Atricure General Information

Description

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 7555 Innovation Way
  • Mason, OH 45040
  • United States
+1 (513)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 7555 Innovation Way
  • Mason, OH 45040
  • United States
+1 (513)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atricure Stock Performance

As of 19-Nov-2026, Atricure’s stock price is $54.03. Its current market cap is $2.76B with 50.9M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$54.03 $55.45 $25.36 - $66.02 $2.76B 50.9M 1.04M $0.31

Atricure Financials Summary

As of 30-Sep-2026, Atricure has a trailing 12-month revenue of $590M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,761,948 1,895,669 1,436,692 1,632,891
Revenue 589,803 534,528 465,307 399,245
EBITDA 37,979 11,767 (22,968) (11,901)
Net Income 14,883 (11,448) (44,698) (30,438)
Total Assets 717,536 654,179 609,328 613,932
Total Debt 93,105 73,381 73,725 74,494
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Atricure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage
Surgical Devices
Mason, OH
1,350 As of 2025

South Jordan, UT
 

Kennesaw, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atricure Competitors (47)

One of Atricure’s 47 competitors is Merit Medical Systems, a Corporation company based in South Jordan, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merit Medical Systems Corporation South Jordan, UT
Artivion Formerly PE-Backed Kennesaw, GA
Cordis Private Equity-Backed Miami Lakes, FL
Elliquence Corporate Backed or Acquired Baldwin, NY
Sisram Medical Formerly PE-Backed Caesarea, Israel
You’re viewing 5 of 47 competitors. Get the full list »

Atricure Patents

Atricure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260345172-A1 Bypass graft friendly exclusion clip Pending 30-Apr-2025
WO-2026231802-A1 Occlusion clip, deployer, and related methods Pending 30-Apr-2025
US-20260341182-A1 Knee amputation training model and methods of use Pending 29-Apr-2025
US-20260256510-A1 Methods and devices for ablation of tissue Pending 28-Feb-2025
WO-2026182789-A1 Methods and devices for ablation of tissue Pending 28-Feb-2025 A61B18/1445
To view Atricure’s complete patent history, request access »

Atricure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atricure Investments & Acquisitions (5)

Atricure’s most recent deal was a Merger/Acquisition with SentreHEART for . The deal was made on 13-Aug-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
SentreHEART 13-Aug-2019 Merger/Acquisition Surgical Devices
nContact 13-Oct-2015 Merger/Acquisition Surgical Devices
Estech 31-Dec-2013 Merger/Acquisition Medical Supplies
CooperSurgical (Frigitronics cryogenic product) 07-Aug-2007 Corporate Asset Purchase Buildings and Property
Enable Medical 10-Aug-2005 Merger/Acquisition Surgical Devices
To view Atricure’s complete investments and acquisitions history, request access »

Atricure ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

27.01 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Atricure’s complete esg history, request access »

Atricure FAQs

  • When was Atricure founded?

    Atricure was founded in 2000.

  • Where is Atricure headquartered?

    Atricure is headquartered in Mason, OH.

  • What is the size of Atricure?

    Atricure has 1,350 total employees.

  • What industry is Atricure in?

    Atricure’s primary industry is Surgical Devices.

  • Is Atricure a private or public company?

    Atricure is a Public company.

  • What is Atricure’s stock symbol?

    The ticker symbol for Atricure is ATRC.

  • What is the current stock price of Atricure?

    As of 19-Nov-2026 the stock price of Atricure is $54.03.

  • What is the current market cap of Atricure?

    The current market capitalization of Atricure is $2.76B.

  • What is Atricure’s current revenue?

    The trailing twelve month revenue for Atricure is $590M.

  • Who are Atricure’s competitors?

    Merit Medical Systems, Artivion, Cordis, Elliquence, and Sisram Medical are some of the 47 competitors of Atricure.

  • What is Atricure’s annual earnings per share (EPS)?

    Atricure’s EPS for 12 months was $0.31.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process